Skip to content
Clinical Trials – home

Thiamine (Vitamin B1): A Comprehensive Guide for Patients

1 / 1
trials open to patients / all trials
1+
Countries

In short

Thiamine, also known as vitamin B1, is being studied in several clinical trials for its potential benefits in various medical conditions. These trials aim to investigate the effects of thiamine supplementation on heart diseases, septic shock, critical illness, and cognitive function. Researchers are exploring how thiamine may improve patient outcomes, cardiac function, oxygen utilization, and overall health in different clinical scenarios.

At a glance

Conditions Studied
Heart failure, septic shock, critical illness, coronary heart disease
Potential Benefits
Improved cardiac function, increased oxygen utilization, reduced lactate levels, better cognitive outcomes
Dosages
Varied across studies, ranging from 25-300 mg daily, administered orally or intravenously
Duration
Ranged from single doses to 28 days of supplementation
Outcome Measures
Left ventricular function, oxygen consumption, lactate clearance, cognitive assessments
Patient Populations
Adults with heart conditions, critically ill patients, older adults undergoing CABG

What is Thiamine?

Thiamine, also known as Vitamin B1, is an essential nutrient that plays a crucial role in various biological processes in our body. It is a water-soluble vitamin, meaning it dissolves in water and is not stored in large amounts in the body. Thiamine is vital for the proper functioning of our nervous system, heart, and muscles.

Other names for thiamine include: Thiamine Hydrochloride Thiamine Chloride Aneurine Hydrochloride B Complex Vitamin

Medical Uses of Thiamine

Thiamine is used to treat or prevent various medical conditions, including:

  • Heart Diseases: Thiamine plays a crucial role in maintaining proper heart function. It is being studied for its potential benefits in patients with heart failure and other cardiac conditions.
  • Wernicke-Korsakoff Syndrome (WKS): This is a brain disorder caused by severe thiamine deficiency, often seen in people with alcohol dependence. Thiamine supplementation is a key treatment for WKS.
  • Thyrotoxicosis: This is a condition where there is excess thyroid hormone in the body. Thiamine supplementation is being studied for its potential to improve cardiovascular function in patients with severe hyperthyroidism.
  • Congenital Heart Diseases: Thiamine is being researched for its potential role in improving heart function in children with certain types of congenital heart defects.
  • Septic Shock: This is a life-threatening condition caused by a severe infection. Researchers are investigating whether thiamine supplementation can improve outcomes in patients with septic shock.

Dosage and Administration

The dosage and method of administration for thiamine can vary depending on the specific medical condition being treated. Here are some examples from ongoing research:

  • For heart diseases in children: Doses ranging from 25 mg to 50 mg per day are being studied.
  • For Wernicke-Korsakoff Syndrome: Higher doses, ranging from 300 mg to 1500 mg per day, are being investigated.
  • For thyrotoxicosis: A dose of 100 mg per day given intravenously (through a vein) is being studied.
  • For septic shock: Doses of 200 mg given twice daily are being researched.

It's important to note that these dosages are from research studies and may not reflect standard treatment. Always follow your healthcare provider's instructions regarding thiamine supplementation.

Benefits of Thiamine Supplementation

Research suggests that thiamine supplementation may offer several potential benefits:

  • Improved Heart Function: Thiamine may help improve the heart's ability to pump blood effectively, which could be beneficial for patients with heart failure.
  • Enhanced Cognitive Function: In patients with thiamine deficiency, supplementation may help improve memory and other cognitive functions.
  • Better Oxygen Utilization: Some studies suggest that thiamine may help the body use oxygen more efficiently, which could be beneficial in critical illnesses.
  • Improved Outcomes in Septic Shock: Thiamine supplementation is being studied for its potential to reduce mortality and improve recovery in patients with septic shock.

Potential Side Effects

Thiamine is generally considered safe when taken as directed. However, as with any medication or supplement, there can be potential side effects. These may include:

  • Allergic reactions (rare)
  • Upset stomach
  • Feeling of warmth

Always inform your healthcare provider about any side effects you experience.

Ongoing Research

Thiamine is the subject of ongoing research in various medical fields. Some areas of current investigation include:

  • Coronary Artery Bypass Grafting (CABG): Researchers are studying whether thiamine supplementation can help improve cognitive function in older adults undergoing CABG surgery.
  • Obesity in Children: Studies are being conducted to assess the prevalence of thiamine deficiency in obese children and its potential implications.
  • Critical Illness: Researchers are investigating the effects of thiamine on oxygen consumption in critically ill patients.

These ongoing studies may provide more insights into the potential benefits and uses of thiamine in various medical conditions.

Questions people often ask

Conditions where Thiamine is being studied

Each condition opens its own overview and trial list

Trials with Thiamine

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).